In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1 - Wikidata - wikimedia - TriplyDB

In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1

In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1

http://www.wikidata.org/entity/Q33725718

about

The molecular basis of HIV entry Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2 Cell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 Envelope Functional stability of unliganded envelope glycoprotein spikes among isolates of human immunodeficiency virus type 1 (HIV-1)Recombinant expression, purification, and biophysical characterization of the transmembrane and membrane proximal domains of HIV-1 gp41.A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1.Multi-Parameter Exploration of HIV-1 Virus-Like Particles as Neutralizing Antibody Immunogens in Guinea Pigs, Rabbits and Macaques Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization A low-molecular-weight entry inhibitor of both CCR5- and CXCR4-tropic strains of human immunodeficiency virus type 1 targets a novel site on gp41 The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.Prime-boost immunization of rabbits with HIV-1 gp120 elicits potent neutralization activity against a primary viral isolate.Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.Increased functional stability and homogeneity of viral envelope spikes through directed evolution.Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected.Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection The role of amino acid changes in the human immunodeficiency virus type 1 transmembrane domain in antibody binding and neutralization Binding of anti-membrane-proximal gp41 monoclonal antibodies to CD4-liganded and -unliganded human immunodeficiency virus type 1 and simian immunodeficiency virus virions Immunogenic Display of Purified Chemically Cross-Linked HIV-1 Spikes.Discrete partitioning of HIV-1 Env forms revealed by viral capture.Assembly and characterization of gp160-nanodiscs: A new platform for biochemical characterization of HIV envelope spikes.Strategies for eliciting HIV-1 inhibitory antibodies Molecular determinants of the ratio of inert to infectious virus particles.Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees Nanoparticle-based flow virometry for the analysis of individual virions Antigenic properties of the HIV envelope on virions in solution.A panel of IgG1 b12 variants with selectively diminished or enhanced affinity for Fcγ receptors to define the role of effector functions in protection against HIV.Dense Array of Spikes on HIV-1 Virion Particles.HIV-1 virus-like particles bearing pure env trimers expose neutralizing epitopes but occlude nonneutralizing epitopes.In vitro assembly of a viral envelope.Rapid, quantitative mapping of anti-HIV type 1 envelope serum antibody specificities.Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at its Apex.Stabilizing the native trimer of HIV-1 Env by destabilizing the heterodimeric interface of the gp41 postfusion six-helix bundle.Topological analysis of HIV-1 glycoproteins expressed in situ on virus surfaces reveals tighter packing but greater conformational flexibility than for soluble gp120.Human immunodeficiency virus type-1 (HIV-1) evades antibody-dependent phagocytosis.HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.FUNCTIONAL OPTIMIZATION OF BROADLY NEUTRALIZING HIV-1 ANTIBODY 10E8 BY PROMOTING MEMBRANE INTERACTIONS.

P2860

Q26863686-7FF78401-EEC1-4C92-A246-DDA1700DDB0C Q27318508-109CAAA7-7036-4BDE-9D0F-613B0AF6CBA2 Q27320687-B6E1FD19-F5A2-4223-A50A-C3DD317818ED Q27675879-E5ECFFF8-FB89-4E9F-80D6-27210ADEABDD Q28263655-E2C64BE5-624C-4121-B342-C3AC2020A81A Q28743199-CDA47F3C-9851-4D9C-A81C-C0A27C45F85C Q30601090-F4C2321E-8693-4906-B330-A40B726BD01B Q31132248-63810ACE-895F-4A69-B585-08D608B54831 Q33683203-C68AE58C-24E4-48DD-B444-77C76780F3B3 Q33946158-13BE4183-678F-4F09-AE32-EA024CA6FA88 Q33966639-503FAA83-ABB8-4263-9B42-ACF3285AF753 Q33999756-9E42FA55-F4D2-4488-8FFE-F2FF7F9454C1 Q34551010-6B23C32E-CD0A-4568-B288-4F8AD53ABD18 Q34555891-E650A840-FA00-4514-B94F-15FFC2B8A1BC Q34611144-0B3E7553-8753-45A2-B9DA-3C956A7D1D36 Q35076987-6D84E375-E881-43CA-9725-9F24CEF1F61E Q35192937-B889AB41-EE97-453A-B6CC-9D5E61BBC5F8 Q35363127-7C3A7E56-7E0E-49C6-9A44-478670ECFFAA Q35644971-713F7757-7365-43F2-98D6-5892109BEE38 Q35689608-0F92F806-A92A-45B5-90B0-4FBA697E3A0D Q35745442-9630DE3A-4B20-45C5-8424-9B5A4ECFBAA2 Q36088254-59F311DE-D047-4A95-B75F-A399C9ECA83B Q36248882-1E586268-7B2A-4102-B9B3-BF629D0FF111 Q36452155-046F5860-E7A4-48F9-9F95-A4C26BDB70D4 Q36494676-91001F84-6E0E-453F-90FF-02228B73D833 Q36978671-E0E96E6B-5517-4AA4-AA1D-865D756B280E Q37123872-88C5A30C-5313-4140-A216-5FE47A0FFA7F Q37547245-2FDCA325-BBF7-4960-A1C1-8BFFC27F6EC8 Q38631835-3399808B-363D-4445-B4AA-FEE3FFBC0115 Q38817990-F128AF97-B28C-43F8-810E-10B8F3560D6B Q39402539-62305CAA-C620-4117-BCB7-4F422357DEA2 Q40142160-53656B3D-4699-44AB-881B-A5CA23C99C28 Q40682905-06A2CA4C-58AE-40BA-A1CD-2A2FF0582D7A Q41924154-6D1087DE-FD61-4E28-9B98-D2EDB572BBAB Q42052623-3BCC7BEB-DF80-49C8-952B-EFCEB97E2D03 Q42572387-3B5924EA-781C-4012-BAA2-0958C7CF4832 Q47215816-A4C2AFF2-E9D7-4BFE-BAA5-F84DD9FC5CD2 Q47423769-EF36E648-9744-400E-9965-9993304D2E30 Q47547492-CEFA39E5-19CB-4202-A038-9BE4B22DE757

P2860

In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1

http://www.wikidata.org/entity/Q33725718

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

In-solution virus capture assa ...... immunodeficiency virus type 1

@ast

In-solution virus capture assa ...... immunodeficiency virus type 1

@en

type

label

In-solution virus capture assa ...... immunodeficiency virus type 1

@ast

In-solution virus capture assa ...... immunodeficiency virus type 1

@en

prefLabel

In-solution virus capture assa ...... immunodeficiency virus type 1

@ast

In-solution virus capture assa ...... immunodeficiency virus type 1

@en

P1433

Q33725718-1D50BE8D-7E6A-4223-899E-BC0CA362056C

P1476

Q33725718-247BCFB4-18B4-4E1F-97D6-C8B4A2A891D7

P2093

Q33725718-2B9FC69E-1B71-42B9-A6D8-C7A0E31A7AEF

Q33725718-C45DD79D-0CC4-45D2-A312-735B988B426F

Q33725718-C8D2E0F7-7436-4C64-9D2E-40DB814F9C5D

P2860

Q33725718-002C5F5C-F8B4-4FA7-990B-BECB752779DC

Q33725718-019E1BCA-E5C6-4914-B218-52E28C38B5BB

Q33725718-0589C295-152D-4CB2-ACA2-DD1A1A16726A

Q33725718-08D0C0D3-9699-456B-A51F-9E2E3AC1F776

Q33725718-0A57F166-3CC6-453E-8407-0ABC7E022BE2

Q33725718-0B3C4AC3-951D-4655-843B-DD1E0A9CC943

Q33725718-0C1E77E2-8F90-4017-BCA3-42A0132B31F8

Q33725718-0DD9A110-9899-41E4-9898-C5563D2BB33C

Q33725718-1022901E-3CF8-45CE-885E-7E2235D29475

Q33725718-11DD0871-CFEB-49EA-8623-F77FF1203CCB

P304

Q33725718-A1A38DFD-D501-4EEF-9393-319B75BD9836

P31

Q33725718-8C944393-7A0F-4EB5-BD55-C6370C7F14E0

P356

Q33725718-CEB2E984-7B17-4CDF-8AAE-11A8A4E89872

P433

Q33725718-B3849179-5AD3-468A-848C-FF09B569ED5B

P478

Q33725718-8A705E33-8737-4B94-9191-E3122C88766F

P577

Q33725718-B7B9EA81-15B2-4F08-899F-2EB5AFE5D190

P698

Q33725718-1F721243-D0B9-464C-BBFB-E99459FD861F

P921

Q33725718-7820B00D-99F7-4FF9-8B56-D181A2563DBB

P932

Q33725718-276216E5-C4DE-48B3-A8DB-6DB0330950DC

P356

P1433

Journal of Virology

P1476

In-solution virus capture assa ...... immunodeficiency virus type 1

@en

P2093

Daniel P Leaman

http://www.w3.org/2001/XMLSchema#string

Heather Kinkead

http://www.w3.org/2001/XMLSchema#string

Michael B Zwick

http://www.w3.org/2001/XMLSchema#string

P2860

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies

Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates

The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well-defined helix in dodecylphosphocholine micelles

HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane

Molecular architecture of native HIV-1 gp120 trimers

A Conformational Switch in Human Immunodeficiency Virus gp41 Revealed by the Structures of Overlapping Epitopes Recognized by Neutralizing Antibodies

Interactions between Lipids and Human Anti-HIV Antibody 4E10 Can Be Reduced without Ablating Neutralizing Activity

Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120

P304

3382-3395

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.02363-09

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20089658

http://www.w3.org/2001/XMLSchema#string

P921

P932

2838137

http://www.w3.org/2001/XMLSchema#string